Masaki Otagiri Selected Research

Reperfusion Injury

11/2020	Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice.
7/2014	Carbon monoxide-bound red blood cell resuscitation ameliorates hepatic injury induced by massive hemorrhage and red blood cell resuscitation via hepatic cytochrome P450 protection in hemorrhagic shock rats.
4/2013	UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin.
10/2010	Albumin fusion of thioredoxin--the production and evaluation of its biological activity for potential therapeutic applications.
7/2010	Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaki Otagiri Research Topics

Disease

24	Neoplasms (Cancer) 03/2022 - 05/2002
16	Chronic Renal Insufficiency 01/2022 - 04/2011
13	Inflammation (Inflammations) 03/2021 - 06/2007
11	Chronic Kidney Failure (Chronic Renal Failure) 11/2021 - 05/2002
10	Hemorrhage 01/2021 - 04/2011
8	Fibrosis (Cirrhosis) 01/2022 - 12/2008
8	Renal Insufficiency (Renal Failure) 11/2021 - 08/2004
8	Hemorrhagic Shock 11/2020 - 06/2009
6	Hypoxia (Hypoxemia) 01/2022 - 02/2015
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2014
6	Infections 01/2021 - 01/2013
6	Ischemia 10/2015 - 03/2007
6	Uremia 09/2009 - 05/2002
5	Lung Injury 11/2020 - 09/2011
5	Reperfusion Injury 11/2020 - 07/2010
5	Wounds and Injuries (Trauma) 01/2020 - 02/2015
5	Anemia 01/2018 - 08/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 09/2017
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 11/2010
4	Secondary Hyperparathyroidism 01/2020 - 04/2011
3	Poisoning 01/2022 - 10/2021
3	Alcoholic Fatty Liver 03/2021 - 01/2020
3	Hypertension (High Blood Pressure) 02/2019 - 12/2009
3	Hepatitis 11/2018 - 04/2014
3	Atrophy 10/2017 - 02/2002
3	Thrombocytopenia (Thrombopenia) 11/2015 - 10/2013
3	Hypoalbuminemia 02/2015 - 05/2006
3	Polyneuropathies (Polyneuropathy) 12/2013 - 08/2005
3	Sepsis (Septicemia) 01/2013 - 04/2011
3	Drug Overdose 10/2005 - 06/2002
2	Fatty Liver 01/2022 - 03/2021
2	Stroke (Strokes) 03/2021 - 12/2020
2	Chronic Disease (Chronic Diseases) 02/2021 - 01/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Rhabdomyolysis 01/2020 - 09/2015
2	Shock 01/2020 - 10/2010
2	Chronic Hepatitis B 01/2020 - 06/2018

Drug/Important Bio-Agent (IBA)

25	AlbuminsIBA 01/2021 - 05/2002
21	Pharmaceutical PreparationsIBA 12/2021 - 05/2002
18	Human Serum Albumin FDA LinkGeneric 08/2021 - 12/2008
18	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2005
14	human S-nitrosoalbuminIBA 01/2020 - 12/2008
13	Therapeutic UsesIBA 01/2022 - 05/2013
12	Hemoglobins (Hemoglobin)IBA 12/2021 - 06/2009
11	Carbon MonoxideIBA 01/2022 - 01/2013
11	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2007
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 08/2005
9	Liposomes (Liposome)IBA 12/2021 - 03/2011
9	AntioxidantsIBA 01/2018 - 04/2011
9	Uremic ToxinsIBA 01/2016 - 05/2002
8	Biological ProductsIBA 11/2020 - 12/2007
7	IndicanIBA 10/2017 - 05/2002
7	CytokinesIBA 01/2016 - 09/2011
6	ThioredoxinsIBA 11/2020 - 09/2011
5	ChitosanIBA 02/2021 - 06/2012
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2013
5	Oxygen (Dioxygen)IBA 01/2016 - 06/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 04/2005
4	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 07/2014
4	Sulfates (Sulfates, Inorganic)IBA 02/2015 - 01/2010
4	Glycoproteins (Glycoprotein)IBA 08/2013 - 07/2007
4	Advanced Glycation End ProductsIBA 04/2011 - 04/2007
3	Cyanides (Isocyanides)IBA 01/2022 - 10/2021
3	MethemoglobinIBA 01/2022 - 10/2021
3	AntidotesIBA 01/2022 - 10/2021
3	SuspensionsIBA 12/2021 - 01/2013
3	Blood Proteins (Serum Proteins)IBA 11/2021 - 04/2009
3	NucleosidesIBA 05/2021 - 06/2018
3	4'-cyano-2'-deoxyguanosineIBA 05/2021 - 06/2018
3	BenzbromaroneIBA 01/2021 - 01/2015
3	ChitinIBA 12/2020 - 09/2016
3	Ether (Diethyl Ether)IBA 02/2019 - 09/2016
3	CyclodextrinsIBA 02/2019 - 09/2016
3	Immunoglobulin M (IgM)IBA 09/2015 - 03/2011
3	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Fibrinogen (Factor I)FDA Link 09/2015 - 08/2013
3	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2015 - 12/2012
3	Hydroxyl RadicalIBA 01/2015 - 10/2008
3	Prealbumin (Transthyretin)IBA 12/2013 - 08/2005
3	Amyloid (Amyloid Fibrils)IBA 12/2013 - 08/2005
3	Serum AlbuminIBA 09/2009 - 08/2008
3	hippuric acidIBA 02/2006 - 04/2005
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 02/2015
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2022 - 10/2021
2	Polysaccharides (Glycans)IBA 01/2022 - 03/2021
2	sacranIBA 01/2022 - 03/2021
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 03/2014
2	Aripiprazole (Abilify)FDA Link 11/2021 - 10/2018
2	Drug CarriersIBA 08/2021 - 12/2010
2	TabletsIBA 02/2021 - 02/2019
2	CytochromesIBA 10/2020 - 01/2013
2	mannose-bovine serum albumin conjugateIBA 01/2020 - 02/2015
2	Concanavalin AIBA 01/2020 - 11/2018
2	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2018
2	Cinacalcet (Sensipar)FDA Link 01/2020 - 01/2017

Therapy/Procedure

18	Therapeutics 10/2021 - 08/2007
15	Renal Dialysis (Hemodialysis) 01/2021 - 08/2004
9	Resuscitation 11/2020 - 06/2009
2	Nephrectomy 01/2022 - 10/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2020